Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges with Personalized Immunotherapy Guided by PD-L1 Expression. J. Anal. Oncol. [Internet]. 2025 Oct. 21 [cited 2025 Oct. 31];14:49-61. Available from: https://www.neoplasiaresearch.com/index.php/jao/article/view/887